290 related articles for article (PubMed ID: 35216409)
21. Regulation of AMH and SCF expression in human granulosa cells by GnRH agonist and antagonist.
Dong M; Huang L; Wang W; Du M; He Z; Mo Y; Yang D
Pharmazie; 2011 Jun; 66(6):436-9. PubMed ID: 21699083
[TBL] [Abstract][Full Text] [Related]
22. [Fertility and cancer].
Poirot C; Sitbon L; Fortin A; Berthaut I; Jaudi S; Anastacio A; Prades M
Presse Med; 2013 Nov; 42(11):1513-20. PubMed ID: 24184281
[TBL] [Abstract][Full Text] [Related]
23. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury.
Oktay K; Sönmezer M; Oktem O; Fox K; Emons G; Bang H
Oncologist; 2007 Sep; 12(9):1055-66. PubMed ID: 17914075
[TBL] [Abstract][Full Text] [Related]
24. Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis.
Elgindy E; Sibai H; Abdelghani A; Mostafa M
Obstet Gynecol; 2015 Jul; 126(1):187-95. PubMed ID: 26241272
[TBL] [Abstract][Full Text] [Related]
25. A Combination of a GnRH Antagonist and Agonist for Fertility Preservation in an Adolescent Female Murine Model.
Knudtson JF; Tellez Santos M; Failor CM; Binkley PA; Venesky JP; Tekmal RR; Robinson RD; Schenken RS
Reprod Sci; 2017 Sep; 24(9):1280-1283. PubMed ID: 28290768
[TBL] [Abstract][Full Text] [Related]
26. Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women.
Blumenfeld Z; Avivi I; Ritter M; Rowe JM
J Soc Gynecol Investig; 1999; 6(5):229-39. PubMed ID: 10554760
[TBL] [Abstract][Full Text] [Related]
27. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy.
Blumenfeld Z; Shapiro D; Shteinberg M; Avivi I; Nahir M
Lupus; 2000; 9(6):401-5. PubMed ID: 10981642
[TBL] [Abstract][Full Text] [Related]
28. Folliculogenesis Is Not Fully Inhibited during GnRH Analogues Treatment in Mice Challenging Their Efficiency to Preserve the Ovarian Reserve during Chemotherapy in This Model.
Horicks F; Van Den Steen G; Houben S; Englert Y; Demeestere I
PLoS One; 2015; 10(9):e0137164. PubMed ID: 26325271
[TBL] [Abstract][Full Text] [Related]
29. A gonadotropin-releasing hormone agonist for the prevention of docetaxel-induced gonadal damage.
Park I; Lee S; Ryu KJ; Min KJ; Hong JH; Song JY; Lee JK; Lee NW
J Obstet Gynaecol; 2017 Aug; 37(6):783-789. PubMed ID: 28502234
[TBL] [Abstract][Full Text] [Related]
30. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models.
Roth C; Hegemann F; Hildebrandt J; Balzer I; Witt A; Wuttke W; Jarry H
Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254
[TBL] [Abstract][Full Text] [Related]
31. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation.
Winship AL; Griffiths M; Lliberos Requesens C; Sarma U; Phillips KA; Hutt KJ
Hum Reprod; 2020 Aug; 35(8):1864-1874. PubMed ID: 32604417
[TBL] [Abstract][Full Text] [Related]
32. [Role of GnRH agonists in preserving female fertility].
Thomin A; Torre A; Daraï É; Chabbert-Buffet N
J Gynecol Obstet Biol Reprod (Paris); 2014 Apr; 43(4):267-74. PubMed ID: 24321862
[TBL] [Abstract][Full Text] [Related]
33. Translational Physiology of Anti-Müllerian Hormone: Clinical Applications in Female Fertility Preservation and Cancer Treatment.
Rodgers RJ; Abbott JA; Walters KA; Ledger WL
Front Endocrinol (Lausanne); 2021; 12():689532. PubMed ID: 34557157
[TBL] [Abstract][Full Text] [Related]
34. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.
Clowse ME; Behera MA; Anders CK; Copland S; Coffman CJ; Leppert PC; Bastian LA
J Womens Health (Larchmt); 2009 Mar; 18(3):311-9. PubMed ID: 19281314
[TBL] [Abstract][Full Text] [Related]
35. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.
Munhoz RR; Pereira AA; Sasse AD; Hoff PM; Traina TA; Hudis CA; Marques RJ
JAMA Oncol; 2016 Jan; 2(1):65-73. PubMed ID: 26426573
[TBL] [Abstract][Full Text] [Related]
36. Infertility in reproductive-age female cancer survivors.
Levine JM; Kelvin JF; Quinn GP; Gracia CR
Cancer; 2015 May; 121(10):1532-9. PubMed ID: 25649243
[TBL] [Abstract][Full Text] [Related]
37. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
38. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure.
Pascuali N; Scotti L; Di Pietro M; Oubiña G; Bas D; May M; Gómez Muñoz A; Cuasnicú PS; Cohen DJ; Tesone M; Abramovich D; Parborell F
Hum Reprod; 2018 May; 33(5):844-859. PubMed ID: 29534229
[TBL] [Abstract][Full Text] [Related]
39. Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents.
Roness H; Kalich-Philosoph L; Meirow D
Hum Reprod Update; 2014; 20(5):759-74. PubMed ID: 24833728
[TBL] [Abstract][Full Text] [Related]
40. [Fertility preservation in adolescents and young adults with cancer].
Rousset-Jablonski C; Chevillon F; Dhedin N; Poirot C
Bull Cancer; 2016 Dec; 103(12):1019-1034. PubMed ID: 27817861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
